LY2228820 dimesylate
LY2228820 dimesylate (Ralimetinib) is a potent, selective, orally available inhibitor p38 MAPK with IC50 of 5.3 and 3.2 nM for p38α and p38β, respectively.
Product Specifications
CAS Number
862507-23-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
612.737
Molecular Formula
C26H37FN6O6S2
Notes
Research use only, not for human use.
Receptor
P38α
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
137564-ML550 100 µL
C-Myc (Myc Proto-oncogene Protein, Class E Basic Helix-loop-helix Protein 39, bHLHe39, Proto-oncogene c-Myc, Transcription Factor p64, BHLHE39, MYC) (MaxLight 550)
Ask
View Details 